SK Biopharm Surpasses Expectations with First Quarter Surplus and Plans for Second Commercial Product Launch

SK Biopharm Surpasses Expectations with First Quarter Surplus and Plans for Second Commercial Product Launch

SK Biopharm gets green light for annual surplus… “We will get the second commercial product soon. “ [이데일리 김진수 기자] SK Biopharm announced its performance in the first quarter of this year and announced on the 9th that it achieved a surplus in operating profit in the first quarter due to rapid growth in sales … Read more

Roche vs. ABL Bio: Bispecific Antibody BBB Shuttle Platform Performance Update

Roche vs. ABL Bio: Bispecific Antibody BBB Shuttle Platform Performance Update

What is the current status of the ‘Roche/ABL Bio’ bispecific antibody BBB shuttle platform performance? [이데일리 김진호 기자] Roche of Switzerland is leading the development of a new dual antibody drug for Alzheimer’s using a brain delivery platform. The company is trying again with the bispecific antibody ‘Trontinemab’, which increased the delivery rate to the … Read more